190 related articles for article (PubMed ID: 18324354)
1. Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas.
Okada H; Low KL; Kohanbash G; McDonald HA; Hamilton RL; Pollack IF
J Neurooncol; 2008 Jul; 88(3):245-50. PubMed ID: 18324354
[TBL] [Abstract][Full Text] [Related]
2. Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomas.
Pollack IF; Jakacki RI; Butterfield LH; Hamilton RL; Panigrahy A; Potter DM; Connelly AK; Dibridge SA; Whiteside TL; Okada H
J Clin Oncol; 2014 Jul; 32(19):2050-8. PubMed ID: 24888813
[TBL] [Abstract][Full Text] [Related]
3. Identification of interleukin-13 receptor alpha2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma.
Joshi BH; Puri RA; Leland P; Varricchio F; Gupta G; Kocak M; Gilbertson RJ; Puri RK;
Neuro Oncol; 2008 Jun; 10(3):265-74. PubMed ID: 18430795
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of tumor-associated antigens in pediatric and adult ependymomas: implication for vaccine therapy.
Yeung JT; Hamilton RL; Okada H; Jakacki RI; Pollack IF
J Neurooncol; 2013 Jan; 111(2):103-11. PubMed ID: 23179498
[TBL] [Abstract][Full Text] [Related]
5. Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomas.
Pollack IF; Jakacki RI; Butterfield LH; Hamilton RL; Panigrahy A; Normolle DP; Connelly AK; Dibridge S; Mason G; Whiteside TL; Okada H
Neuro Oncol; 2016 Aug; 18(8):1157-68. PubMed ID: 26984745
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study.
Pollack IF; Jakacki RI; Butterfield LH; Hamilton RL; Panigrahy A; Normolle DP; Connelly AK; Dibridge S; Mason G; Whiteside TL; Okada H
J Neurooncol; 2016 Dec; 130(3):517-527. PubMed ID: 27624914
[TBL] [Abstract][Full Text] [Related]
7. [Research on relationship of survivin gene expression with malignant proliferation and apoptosis of brain glioma].
Zhen HN; Zhang X; Hu PZ; Fu LA; Yang TT; Ma FC; Wang XL; Liang JW
Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(13):885-8. PubMed ID: 16083611
[TBL] [Abstract][Full Text] [Related]
8. [Nuclear and cytoplasmic expressions of survivin in glioma and their prognostic value].
Pan Y; Hu WH; Xie D; Wu QL; Liu YH; Xiang J; Wu HX
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):325-9. PubMed ID: 17456361
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy.
Wykosky J; Gibo DM; Stanton C; Debinski W
Clin Cancer Res; 2008 Jan; 14(1):199-208. PubMed ID: 18172271
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index.
Uematsu M; Ohsawa I; Aokage T; Nishimaki K; Matsumoto K; Takahashi H; Asoh S; Teramoto A; Ohta S
J Neurooncol; 2005 May; 72(3):231-8. PubMed ID: 15937645
[TBL] [Abstract][Full Text] [Related]
11. [Nuclear expression of Survivin in glioma and its correlation to prognosis].
Pan Y; Hu WH; Xie D; Wu HX; Xiang J; Liu YD; Wu QL; Liu YH
Ai Zheng; 2006 May; 25(5):635-9. PubMed ID: 16687089
[TBL] [Abstract][Full Text] [Related]
12. Identification of a human leukocyte antigen-A24-restricted T-cell epitope derived from interleukin-13 receptor alpha2 chain, a glioma-associated antigen.
Shimato S; Natsume A; Wakabayashi T; Tsujimura K; Nakahara N; Ishii J; Ito M; Akatsuka Y; Kuzushima K; Yoshida J
J Neurosurg; 2008 Jul; 109(1):117-22. PubMed ID: 18590440
[TBL] [Abstract][Full Text] [Related]
13. Survivin expression in ganglioglioma.
Rousseau A; Kujas M; Bergemer-Fouquet AM; van Effenterre R; Hauw JJ
J Neurooncol; 2006 Apr; 77(2):153-9. PubMed ID: 16292482
[TBL] [Abstract][Full Text] [Related]
14. [Apoptosis of glioma cell line U251 induced by small interfering RNA targeting survivin].
Xu RX; Tu YY; Jiang XD; Feng JN; Huang J
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):398-401. PubMed ID: 16624736
[TBL] [Abstract][Full Text] [Related]
15. Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas.
Zhen HN; Zhang X; Hu PZ; Yang TT; Fei Z; Zhang JN; Fu LA; He XS; Ma FC; Wang XL
Cancer; 2005 Dec; 104(12):2775-83. PubMed ID: 16284993
[TBL] [Abstract][Full Text] [Related]
16. Quantitatively determined survivin expression levels are of prognostic value in human gliomas.
Chakravarti A; Noll E; Black PM; Finkelstein DF; Finkelstein DM; Dyson NJ; Loeffler JS
J Clin Oncol; 2002 Feb; 20(4):1063-8. PubMed ID: 11844831
[TBL] [Abstract][Full Text] [Related]
17. Ciglitazone induces caspase-independent apoptosis through down-regulation of XIAP and survivin in human glioma cells.
Kang DW; Choi CH; Park JY; Kang SK; Kim YK
Neurochem Res; 2008 Mar; 33(3):551-61. PubMed ID: 17940898
[TBL] [Abstract][Full Text] [Related]
18. Survivin in brain tumors: an attractive target for immunotherapy.
Katoh M; Wilmotte R; Belkouch MC; de Tribolet N; Pizzolato G; Dietrich PY
J Neurooncol; 2003; 64(1-2):71-6. PubMed ID: 12952288
[TBL] [Abstract][Full Text] [Related]
19. Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade.
Altura RA; Olshefski RS; Jiang Y; Boué DR
Br J Cancer; 2003 Nov; 89(9):1743-9. PubMed ID: 14583779
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of survivin, midkine and CXCR4 promoters for transcriptional targeting of glioma gene therapy.
Ulasov IV; Rivera AA; Sonabend AM; Rivera LB; Wang M; Zhu ZB; Lesniak MS
Cancer Biol Ther; 2007 May; 6(5):679-85. PubMed ID: 17404502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
